Mar 05, 2019
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma
Mar 03, 2019
Immutep to Present at Oppenheimer’s 29th Annual Healthcare Conference
Feb 26, 2019
Immutep to Present at Upcoming Industry Conferences
Jan 07, 2019
Immutep Enters into Clinical Trial Collaboration, Service and Supply Agreement with Cytlimic
Dec 19, 2018
Immutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital
